These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25684642)

  • 41. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
    Inglis SC; McMurray JJ; Böhm M; Schaufelberger M; van Veldhuisen DJ; Lindberg M; Dunselman P; Hjalmarson A; Kjekshus J; Waagstein F; Wedel H; Wikstrand J;
    Eur J Heart Fail; 2010 Jul; 12(7):698-705. PubMed ID: 20501489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statin use and survival outcomes in elderly patients with heart failure.
    Ray JG; Gong Y; Sykora K; Tu JV
    Arch Intern Med; 2005 Jan; 165(1):62-7. PubMed ID: 15642876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
    White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
    J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do statins improve heart failure outcome in post-myocardial infarction patients with moderate to severe left ventricular dysfunction?
    Sankaranarayanan R; Maini S; James MA; Burtchaell S; Chatterjee AK
    Congest Heart Fail; 2010; 16(4):181-6. PubMed ID: 20662872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin-mediated low-density lipoprotein lowering in chronic congestive heart failure.
    Kosmas CE; Alkhawam H; El-Hunjul M; Wagman G; Kahn MR; Grady KM; Vittorio TJ
    Am J Med Sci; 2014 Jan; 347(1):14-22. PubMed ID: 23154655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
    Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statins reduce peri-procedural complications in carotid stenting.
    Reiff T; Amiri H; Rohde S; Hacke W; Ringleb PA
    Eur J Vasc Endovasc Surg; 2014 Dec; 48(6):626-32. PubMed ID: 25240903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [No reason to start treatment with statins in patients with moderate to severe heart failure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):486-8. PubMed ID: 18389878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should a statin be prescribed to every patient with heart failure?
    Tsouli SG; Liberopoulos EN; Goudevenos JA; Mikhailidis DP; Elisaf MS
    Heart Fail Rev; 2008 Jun; 13(2):211-25. PubMed ID: 17694432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Badar AA; Perez-Moreno AC; Jhund PS; Wong CM; Hawkins NM; Cleland JG; van Veldhuisen DJ; Wikstrand J; Kjekshus J; Wedel H; Watkins S; Gardner RS; Petrie MC; McMurray JJ
    Eur Heart J; 2014 Dec; 35(48):3426-33. PubMed ID: 25265976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
    Kristensen SL; Jhund PS; Køber L; Preiss D; Kjekshus J; McKelvie RS; Zile MR; Anand IS; Wikstrand J; Wedel H; Komajda M; Carson PE; Cleland JG; McMurray JJ
    Eur J Heart Fail; 2015 Feb; 17(2):169-76. PubMed ID: 25756844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statin use prior to first myocardial infarction in contemporary patients: Inefficient and not gender equitable.
    Kulenovic I; Mortensen MB; Bertelsen J; May O; Dodt KK; Kanstrup H; Falk E
    Prev Med; 2016 Feb; 83():63-9. PubMed ID: 26687101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statins in heart failure-where do we stand?
    Lyons KS; McVeigh GE; Harbinson MT
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):99-104. PubMed ID: 21136284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin Lipophilicity and the Risk of Incident Heart Failure.
    Imran T; Wong A; Schneeweiss S; Desai RJ
    Cardiology; 2020; 145(6):375-383. PubMed ID: 32289796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Heart; 2008 Sep; 94(9):1138-40. PubMed ID: 18703694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk.
    Laufs U; Custodis F; Böhm M
    Drugs; 2006; 66(2):145-54. PubMed ID: 16451090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).
    Perez AC; Jhund PS; Stott DJ; Gullestad L; Cleland JG; van Veldhuisen DJ; Wikstrand J; Kjekshus J; McMurray JJ
    JACC Heart Fail; 2014 Feb; 2(1):35-40. PubMed ID: 24622117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF.
    Lavie CJ; Mehra MR
    Congest Heart Fail; 2009; 15(4):157-8. PubMed ID: 19627287
    [No Abstract]   [Full Text] [Related]  

  • 60. Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
    Røysland R; Masson S; Omland T; Milani V; Bjerre M; Flyvbjerg A; Di Tano G; Misuraca G; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
    Am Heart J; 2010 Aug; 160(2):286-93. PubMed ID: 20691834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.